36 results
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... Multidrug-Resistant Tuberculosis ... #MDRTB #management ... pharmacology #dosing #idsa
Gastroesophageal Reflux Disease (GERD) Summary
 - Diagnosis
 - Clinical Workflow
 - PPIs
 - Treatment
 - Acid
- Diagnosis - Clinical ... Workflow - PPIs - Treatment ... Disease #GERD #gastroenterology ... #diagnosis #management
Factors to be considered in deciding to initiate treatment empirically for active tuberculosis (TB) (prior to
deciding to initiate treatment ... empirically for active tuberculosis ... #ActiveTB #tuberculosis ... #initiation #management ... #IDSA
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... GrepMed Handbook Clinical ... (IDSA 2021): ... /severe CDI IDSA ... #IDSA #gastroenterology
COVID-19 Diagnosis and Management Summary
Clinical and laboratory testing
Lung Ultrasound
HRCT scan
In-hospital treatment
Severity assessment and respiratory support 
Post-mortem
Diagnosis and Management ... Summary Clinical ... testing Lung Ultrasound ... scan In-hospital treatment ... #Summary #treatment
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... - IDSA Guidelines ... or TEE unless clinical ... #Candidemia #IDSA ... #candidiasis #treatment
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... multidrug-resistant tuberculosis ... MultiDrugResistant #Tuberculosis ... #MDRTB #management ... pharmacology #ebm #idsa
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Adjuvant therapies in critical ... meningitis - Tuberculous ... meningitis - Tuberculous ... #Pharmacology #Management ... #Treatment #Indications
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Treatment: Active ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Multi-Drug Resistant Tuberculosis ... #MDRTB #management ... pharmacology #dosing #idsa